FDA Inspection
Eli Lilly & CompanyEli Lilly & Company – FDA Inspection, Jun 16, 2023
Record Details
This FDA Inspection record concerns Eli Lilly & Company, with an inspection on June 16, 2023, issued by the Detroit District Office.
- Company
- Eli Lilly & Company
- Inspection Date
- June 16, 2023
View Company Profile
ID · 1b0c9a3d-bf7d-4880-9595-6260abeca3ef
Inspection Facts
- Inspection number
- 1209522
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Eli Lilly & Company
35| Date | Classification | Office | Project area |
|---|---|---|---|
| January 9, 2026 | NAI | Bioresearch Monitoring | |
| May 20, 2025 | VAI | Detroit District Office | Drug Quality Assurance |
| March 27, 2025 | Not classified | Detroit District Office | |
| January 15, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 6, 2023 | Not classified | Detroit District Office |
Other documents for Eli Lilly & Company
- FDA Inspection 1298628 - 2026-01-09
- FDA Inspection 1270621 - 2025-05-20
- FDA Inspection 1260339 - 2025-03-27
- FDA Inspection 1229895 - 2025-01-15
- FDA Inspection 1220489 - 2023-10-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.